-
Mashup Score: 135
An analysis of the SWOG S1216 study supports that a deep prostate-specific antigen response at 3 or 7 mo after starting treatment for metastatic hormone-sensitive prostate cancer is prognostic for overall survival, regardless of front-line treatment received with androgen deprivation therapy.
Source: euoncology.europeanurology.comCategories: General Medicine News, Oncologists1Tweet
-
Mashup Score: 20Reviewers for the Journal, July–December 2023 | NEJM - 3 month(s) ago
Editorial from The New England Journal of Medicine — Reviewers for the Journal, July–December 2023
Source: www.nejm.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 48Program Guide – ASCO Meeting Program Guide - 3 month(s) ago
Cristiane Decat Bergerot Oncoclinicas, BrasĂlia, Brazil Cristiane Decat Bergerot, Daniela V. Castro, Paulo Gustavo Bergerot, Benjamin D. Mercier, Elizabeth Nally, Adil A. Ali, Errol James Philip, Murilo Buso, Thomas E. Hutson, Viktor GrĂĽnwald, Axel Bex, Sarah P. Psutka, Brian I. Rini, Elizabeth R. Plimack, Viraj A. Master, Laurence Albiges, Toni K. Choueiri, Sumanta Kumar Pal, Thomas Powles Oncoclinicas, BrasĂlia, Brazil, City of Hope Comprehensive Cancer Center, Duarte, CA, St Bart’s Hospital, Emory
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 36Program Guide – ASCO Meeting Program Guide - 3 month(s) ago
Rebecca Hassoun Indiana University Simon Comprehensive Cancer Center, Indianapolis, IN Rebecca Hassoun, Clint Cary, Timothy A. Masterson, George Laliotis, Shruti Sharma, Punashi Dutta, Meenakshi Malhotra, Adam ElNaggar, Minetta C. Liu, John P. Sfakianos, Jennifer King, Lawrence H. Einhorn, Nabil Adra Indiana University Simon Comprehensive Cancer Center, Indianapolis, IN, Natera, Inc., Austin, TX, Icahn School of Medicine at Mount Sinai, New York, NY Background: Serum tumor markers (STM) are currently
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 43Program Guide – ASCO Meeting Program Guide - 3 month(s) ago
Syed Muneeb Alam Memorial Sloan Kettering Cancer Center, New York, NY Syed Muneeb Alam, Min Yuen Teo, Jun Woo, Michal Sarfaty, Samuel A Funt, David H Aggen, Chung-Han Lee, Marie Isabel Carlo, Jatin Gandhi, Neha Ratna, Ashley M. Regazzi, Mark Donoghue, Dean F. Bajorin, Jonathan Coleman, Jonathan E. Rosenberg, Hikmat A. Al-Ahmadie, David B. Solit, Gopa Iyer Memorial Sloan Kettering Cancer Center, New York, NY Ruth L. Kirschstein Institutional National Research Service Award (T32) Background: Microsatellite
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 60Program Guide – ASCO Meeting Program Guide - 3 month(s) ago
Nizar M. Tannir Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX Nizar M. Tannir, Bernard Escudier, David F. McDermott, Mauricio Burotto, Toni K. Choueiri, Hans J. Hammers, Elizabeth R. Plimack, Camillo Porta, Saby George, Thomas Powles, Frede Donskov, Michael B. Atkins, Christian K. Kollmannsberger, Marc-Oliver Grimm, Yoshihiko Tomita, Brian I. Rini, Ruiyun Jiang, Heshani Desilva, Chung-Wei Lee, Robert J. Motzer Department of Genitourinary
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet-
Ab#363 @ASCO #GU24 by #NizarTannir👉https://t.co/hF1SNo8UWt👉CheckMate214 ph3 mRCC #kidneycancerupdate at 80 mof/u👉Ipi+Nivo continues to show survival benefits vs Sunitinib➡️ mOS 47 vs 26 mos in int/poor risk pts👇@motzermd @OncoAlert @urotoday @Uromigos @KidneyCancer https://t.co/R96OJ7U9sA
-
-
Mashup Score: 44Program Guide – ASCO Meeting Program Guide - 3 month(s) ago
Viktor GrĂĽnwald University Hospital Essen, Essen, Germany Viktor GrĂĽnwald, Robert J. Motzer, John B. A. G. Haanen, Manuela Schmidinger, Michael D. Staehler, Jeffrey C. Goh, Eric Voog, Miguel Climent Duran, Saby George, Joseph E. Burgents, Ran Xie, Jodi McKenzie, Camillo Porta University Hospital Essen, Essen, Germany, Memorial Sloan Kettering Cancer Center, New York, NY, Netherlands Cancer Institute, Amsterdam, Netherlands, Medical University of Vienna, Vienna, Austria, University Hospital of Munich,
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet-
Ab#364 @ASCO #GU24 by @ViktorGruenwald👉 https://t.co/BrvjNXvTKr 👉 in the ph3 CLEAR trial in pts w/ mRCC #kidneycancer 👉OS, PFS & ORR benefit of Lenvatinib+Pembro vs sunitinib persist regardless of primary tumor size👇@CPRT65 @OncoAlert @urotoday @Uromigos @KidneyCancer https://t.co/lzjBbjs546
-
-
Mashup Score: 36Program Guide – ASCO Meeting Program Guide - 3 month(s) ago
Rebecca Hassoun Indiana University Simon Comprehensive Cancer Center, Indianapolis, IN Rebecca Hassoun, Clint Cary, Timothy A. Masterson, George Laliotis, Shruti Sharma, Punashi Dutta, Meenakshi Malhotra, Adam ElNaggar, Minetta C. Liu, John P. Sfakianos, Jennifer King, Lawrence H. Einhorn, Nabil Adra Indiana University Simon Comprehensive Cancer Center, Indianapolis, IN, Natera, Inc., Austin, TX, Icahn School of Medicine at Mount Sinai, New York, NY Background: Serum tumor markers (STM) are currently
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 34Program Guide – ASCO Meeting Program Guide - 3 month(s) ago
Sofiya Semko Department of Urology, University Hospital of Cologne, Cologne, Germany Sofiya Semko, Axel Heidenreich, Pia Paffenholz, David A. Pfister, Maksym Pikul Department of Urology, University Hospital of Cologne, Cologne, Germany, Department of Urology, Uro-Oncology, Robot Assisted and Reconstructive Urologic Surgery, University of Cologne Faculty of Medicine and University Hospital Cologne, Cologne, Germany Background: Present study aimed to gain insight into whether patients with high-risk
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet
-
Mashup Score: 32Program Guide – ASCO Meeting Program Guide - 3 month(s) ago
Reuben Ben-David Icahn School of Medicine At Mount Sinai, New York, NY Reuben Ben-David, Alex Chehrazi-Raffle, George Laliotis, Neeraja Tillu, Shivaram Cumarasamy, Jordan Rich, Kevin Manage, Shruti Sharma, Punashi Dutta, Meenakshi Malhotra, Adam ElNaggar, Minetta C. Liu, Adam Rock, Tanya B. Dorff, John P. Sfakianos Icahn School of Medicine At Mount Sinai, New York, NY, City of Hope Comprehensive Cancer Center, Duarte, CA, Natera, Inc., Austin, TX, Icahn School of Medicine at Mount Sinai, New York, NY
Source: meetings.asco.orgCategories: General Medicine News, Hem/OncsTweet-
Ab#499 @ASCO #GU24 by @ReubenBenDavid1👉https://t.co/PLKTmZhj1D👉 pts w/ NSGCT #testicularcancer w/ +ve ctDNA have shorter event-free survival vs pts w/-ve ctDNA👉ctDNA as promising biomarker for EFS👇👇@DrJohnSfakianos @OncoAlert @urotoday @Uromigos @TCSociety @CityofHope_GU https://t.co/qkc1PaptHr
-
Just in 👉data from @SWOG 1216 trial in mHSPC#prostatecancer👉 PSA level at 3 and 7 months after starting ADT Rx are strongly prognostic of OS: It’s time to design de- or escalation trials based on response biomarkers. OPEN access👉 https://t.co/UC5B1E49X9 @OncoAlert @urotoday https://t.co/HcHTHHqHOs